2407
COM:GAUSH
高视医疗集团
- Stock
Last Close
9.81
25/11 07:59
Market Cap
1.69B
Beta: -
Volume Today
601.30K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|
average inventory | 239.84M - | 260.61M 8.66% | 304.82M 16.96% | |
average payables | 86.22M - | 68.36M 20.71% | 79.63M 16.49% | |
average receivables | 172.49M - | 84.32M 51.11% | 158.87M 88.41% | |
book value per share | -6.61 - | 15.33 332.05% | 11.46 25.24% | |
capex per share | 0.29 - | 0.50 69.23% | 0.31 37.80% | |
capex to depreciation | 0.47 - | 0.73 56.37% | 0.60 17.81% | |
capex to operating cash flow | 0.17 - | 0.20 20.11% | 0.18 10.60% | |
capex to revenue | 0.02 - | 0.04 77.25% | 0.03 15.33% | |
cash per share | 6.35 - | 8.40 32.16% | 5.63 32.99% | |
days of inventory on hand | 127.25 - | 163.27 28.31% | 167.79 2.77% | |
days payables outstanding | 36.05 - | 39.90 10.70% | 46.26 15.92% | |
days sales outstanding | 48.36 - | 49.10 1.53% | 38.70 21.18% | |
debt to assets | 0.40 - | 0.26 34.84% | 0.22 15.73% | |
debt to equity | -1.46 - | 0.48 132.60% | 0.37 22.90% | |
dividend yield | ||||
earnings yield | -0.05 - | -0.08 66.90% | 0.04 145.36% | |
enterprise value | 4.36B - | 4.45B 1.91% | 4.87B 9.60% | |
enterprise value over ebitda | 11.45 - | 31.60 175.94% | 13.02 58.79% | |
ev to operating cash flow | 26.53 - | 18.97 28.50% | 19.57 3.17% | |
ev to sales | 3.36 - | 3.55 5.52% | 3.47 2.28% | |
free cash flow per share | 1.42 - | 1.92 35.07% | 1.37 28.52% | |
free cash flow yield | 0.03 - | 0.04 24.21% | 0.04 0.26% | |
graham net net | -22.98 - | -1.55 93.26% | -0.25 83.60% | |
graham number | 17.50 - | 35.07 100.41% | 17.30 50.66% | |
income quality | -1.19 - | -0.85 28.53% | 1.44 268.42% | |
intangibles to total assets | 0.49 - | 0.44 10.78% | 0.43 0.75% | |
interest coverage | 3.84 - | 1.76 54.28% | 5.81 230.78% | |
interest debt per share | 10.90 - | 7.68 29.58% | 4.52 41.12% | |
inventory turnover | 2.87 - | 2.24 22.07% | 2.18 2.69% | |
invested capital | 1.92B - | 2.15B 11.74% | 1.86B 13.50% | |
market cap | 4.01B - | 4.41B 10.00% | 4.83B 9.42% | |
net current asset value | -1.97B - | 94.93M 104.82% | 244.10M 157.14% | |
net debt to ebitda | 0.92 - | 0.24 73.50% | 0.12 50.20% | |
net income per share | -1.99 - | -3.61 81.48% | 1.17 132.51% | |
operating cash flow per share | 1.72 - | 2.42 40.89% | 1.68 30.42% | |
payables turnover | 10.13 - | 9.15 9.66% | 7.89 13.73% | |
receivables turnover | 7.55 - | 7.43 1.51% | 9.43 26.87% | |
research and ddevelopement to revenue | 0.02 - | 0.03 81.00% | 0.04 14.75% | |
return on tangible assets | -0.15 - | -0.23 48.57% | 0.11 147.16% | |
revenue per share | 13.55 - | 12.93 4.53% | 9.50 26.54% | |
roe | 0.29 - | -0.24 182.00% | 0.10 143.40% | |
roic | 1.46 - | 0.04 96.97% | 0.09 101.63% | |
sales general and administrative to revenue | 0.10 - | 0.12 15.08% | 0.09 21.08% | |
shareholders equity per share | -6.85 - | 15.16 321.31% | 11.35 25.11% | |
stock based compensation to revenue | ||||
tangible asset value | -1.82B - | 300.93M 116.54% | 465.77M 54.78% | |
tangible book value per share | -18.99 - | 3.10 116.35% | 3.15 1.37% | |
working capital | 648.55M - | 833.71M 28.55% | 499.17M 40.13% |
All numbers in HKD (except ratios and percentages)